Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ROP vs GSK✓SelectedUSD · GSKROP vs GSK performance historyLatest closeAs of-0.68%11/20
Stock and ETF performance explorer

ROP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+168.8%
GSK return
+97.4%
Excess return
+71.3%
Maximum drawdown
-46.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-0.1%-0.6%-0.6%
7D-4.2%-5.3%+1.1%-2.6%
30D+15.7%-3.7%+19.3%+17.0%
3M+12.3%-7.3%+19.6%+14.8%
6M+43.0%-4.2%+47.3%+44.4%
YTD+4.3%+0.9%+3.4%+2.8%
1Y+5.3%+7.3%-2.0%+1.7%
3Y-10.5%+52.7%-63.2%-26.1%
5Y-4.6%+40.1%-44.8%-20.1%
All+168.8%+97.4%+71.3%+91.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling